je.st
news
Novartis Comes Under Fire: Consider Newer Startup Imprimis Instead
2015-12-02 17:46:48| Biotech - Topix.net
A drive for governmental regulations on drug prices is likely to have a dampening effect on Novartis's stock values. Other companies, such as Imprimis, may provide a better investment option, as they step in to offer drugs at much cheaper prices than major players like Novartis.
Tags: instead
fire
newer
startup
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|